Bio-orthogonal click-targeting nanocomposites for chemo-photothermal synergistic therapy in breast cancer.


Journal

Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395

Informations de publication

Date de publication:
2020
Historique:
received: 25 11 2019
accepted: 08 03 2020
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 27 7 2021
Statut: epublish

Résumé

Chemo-photothermal synergistic treatment has a high potential to complement traditional cancer therapy and amplify its outcome. Precision in the delivery of these therapeutic agents to tumor cells has been indicated as being key to maximizing their therapeutic effects.

Identifiants

pubmed: 32373214
doi: 10.7150/thno.42445
pii: thnov10p5305
pmc: PMC7196291
doi:

Substances chimiques

Antineoplastic Agents 0
Doxorubicin 80168379AG

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5305-5321

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

Adv Drug Deliv Rev. 2011 Mar 18;63(3):131-5
pubmed: 20304019
J Cell Biol. 1983 May;96(5):1475-9
pubmed: 6302102
Biomaterials. 2019 Jun;205:1-10
pubmed: 30889497
Adv Mater. 2014 Dec 23;26(48):8154-62
pubmed: 25331930
Chem Biol. 2007 Jan;14(1):107-15
pubmed: 17254956
Nat Chem Biol. 2017 Apr;13(4):415-424
pubmed: 28192414
J Control Release. 2012 Dec 10;164(2):187-91
pubmed: 22537887
ACS Nano. 2019 Mar 26;13(3):3691-3702
pubmed: 30790523
J Control Release. 2018 Feb 28;272:107-113
pubmed: 29355618
Science. 1984 Oct 26;226(4673):466-8
pubmed: 6093249
Biomaterials. 2016 Jan;74:144-54
pubmed: 26454052
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794
pubmed: 29711117
Science. 2000 Mar 17;287(5460):2007-10
pubmed: 10720325
Adv Sci (Weinh). 2016 May 24;4(1):1600106
pubmed: 28105389
Chem Soc Rev. 2019 Apr 1;48(7):2053-2108
pubmed: 30259015
Crit Rev Biomed Eng. 2010;38(1):101-16
pubmed: 21175406
Biomaterials. 2010 May;31(13):3657-66
pubmed: 20138662
Biomaterials. 2016 Jul;94:70-83
pubmed: 27105438
Biomaterials. 2017 Sep;139:12-29
pubmed: 28582715
J Med Chem. 2006 Oct 5;49(20):6087-93
pubmed: 17004722
Angew Chem Int Ed Engl. 2012 Nov 19;51(47):11836-40
pubmed: 23081905
Chem Rev. 2017 Nov 22;117(22):13566-13638
pubmed: 29048884
J Control Release. 2018 Aug 28;284:1-14
pubmed: 29886061
Chem Rev. 2014 Nov 12;114(21):10869-939
pubmed: 25260098
Mol Pharm. 2008 Jul-Aug;5(4):505-15
pubmed: 18672949
ACS Nano. 2015 Oct 27;9(10):9626-37
pubmed: 26365698
Asian J Pharm Sci. 2019 Sep;14(5):531-542
pubmed: 32104480
Clin Cancer Res. 2002 Apr;8(4):1172-81
pubmed: 11948130
Nano Lett. 2019 Feb 13;19(2):937-947
pubmed: 30688465
Angew Chem Int Ed Engl. 2016 Nov 14;55(47):14698-14703
pubmed: 27762044
Science. 2008 May 2;320(5876):664-7
pubmed: 18451302
ACS Nano. 2018 Dec 26;12(12):12269-12283
pubmed: 30418749
ACS Nano. 2019 Feb 26;13(2):2544-2557
pubmed: 30730695
Int J Pharm. 2017 Apr 15;521(1-2):19-32
pubmed: 28163230
J Control Release. 2019 Mar 10;297:39-47
pubmed: 30684512
ACS Nano. 2013 Nov 26;7(11):9947-60
pubmed: 24073739
Theranostics. 2020 Jan 1;10(2):615-629
pubmed: 31903141
Adv Mater. 2014 Oct 8;26(37):6401-8
pubmed: 25123089
ACS Nano. 2018 Mar 27;12(3):2610-2622
pubmed: 29451774
Adv Sci (Weinh). 2018 Feb 26;5(5):1700891
pubmed: 29876215
ACS Nano. 2014 Mar 25;8(3):2048-63
pubmed: 24499346
Nat Rev Cancer. 2014 Mar;14(3):199-208
pubmed: 24561446
Adv Healthc Mater. 2016 Sep;5(17):2227-36
pubmed: 27377242
Adv Mater. 2019 Feb;31(5):e1805936
pubmed: 30537012
ACS Nano. 2017 Sep 26;11(9):8930-8943
pubmed: 28892360
Angew Chem Int Ed Engl. 2017 Jul 24;56(31):9155-9159
pubmed: 28628725
Colloids Surf B Biointerfaces. 2018 Jan 1;161:356-364
pubmed: 29100129
Theranostics. 2015 Jan 20;5(4):345-56
pubmed: 25699095
J Control Release. 2016 Apr 28;228:107-119
pubmed: 26941036
Biomater Sci. 2018 May 1;6(5):1201-1216
pubmed: 29578215
Acta Biomater. 2018 Jul 15;75:398-412
pubmed: 29874597
ACS Appl Mater Interfaces. 2018 Jan 31;10(4):4271-4284
pubmed: 29318879
Nanomedicine (Lond). 2014 Sep;9(13):2003-22
pubmed: 25343350
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14773-8
pubmed: 18815374
Theranostics. 2016 Jun 16;6(9):1467-76
pubmed: 27375793

Auteurs

Jianan Qiao (J)

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Stability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

Fengchun Tian (F)

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Stability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

Yudi Deng (Y)

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Stability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

Yunkai Shang (Y)

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Stability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

Shijie Chen (S)

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Stability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

Enhao Chang (E)

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Stability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

Jing Yao (J)

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Stability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH